Chee Yeun Chung

What if a pinch of Baker’s yeast could be just the recipe to solve the most complex neurological diseases?

Apply to Attend TEDMED 2018
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 14 - 16, 2018.
Apply Today!

Have a suggestion for The Hive?
Submit a Nomination Today

Share This Talk

About Chee Yeun Chung

Dr. Chee Yeun Chung is a member of Yumanity’s core research team and is a scientific co-founder who made seminal contributions to both the company’s neuronal and yeast discovery platforms. Dr. Chung is a graduate of Ewha Woman’s University in Seoul, South Korea, where she earned a bachelor of pharmacy degree. She then obtained her Ph.D. at the University of California, Davis. Prior to joining Yumanity, she was an instructor at Harvard Medical School, subsequently joining the Lindquist lab at the Whitehead Institute as a senior research scientist in 2009. She developed assays that have identified abnormalities in rat and human iPSc-based cortical neuron culture system, revealing critical mechanisms of neurodegenerative diseases.

Find out more

About This Idea

Chee Yeun Chung is Scientific Co-founder and Associate Director of Assay Development at Yumanity Therapeutics, a company working to develop new treatments for neurodegenerative diseases that are caused from protein misfolding. Currently, there are over 55 million people affected by these diseases, with no effective cures or treatment options to improve their conditions. Watch Chee's 2017 TEDMED Hive Talk to learn more about Yumanity's goal to develop novel therapies aimed at improving the prognosis for the millions of patients affected by neurodegenerative diseases worldwide.

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.